Skip to content
Seqlense EUR-Lex

Commission Regulation (EU) No 186/2014 of 26 February 2014 amending Regulation (EU) No 823/2012 as regards the expiry dates of the approval of the active substances ethoxysulfuron, oxadiargyl and warfarin Text with EEA relevance

CELEX
32014R0186
Document type
REG
Sector
Legislation
Date of document
2014-02-26
In force since
2014-03-19
Status
In force

Text

Article-level text, parsed from the formex manifestation.

Article 1 Amendments to Regulation (EU) No 823/2012

Article 1 of Regulation (EU) No 823/2012 is amended as follows: (a) point (1) is replaced by the following: ‘(1) 31 July 2016, as regards the active substances: ethofumesate (entry 29), imazamox (entry 41), oxasulfuron (entry 42), foramsulfuron (entry 44), cyazofamid (entry 46), linuron (entry 51), pendimethalin (entry 53), trifloxystrobin (entry 59), carfentrazone ethyl (entry 60), mesotrione (entry 61), fenamidone (entry 62) and isoxaflutole (entry 63);’; (b) the following point (4) is added: ‘(4) 31 March 2014, as regards the active substances: ethoxysulfuron (entry 43), oxadiargyl (entry 45) and warfarin (entry 120).’

Article 2 Entry into force

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Relations

What this act cites, and what cites it.

Show relations

Versions

Point-in-time consolidated versions of this act.

Show versions